Pharming management to meet with Oppenheimer
PremiumThe FlyPharming management to meet with Oppenheimer
8M ago
Pharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
PremiumThe Fly
Pharming Group price target raised to EUR 1.90 from EUR 1.80 at RBC Capital
12M ago
Pharming enrolls first patient in leniolisib trial in Japan
PremiumThe Fly
Pharming enrolls first patient in leniolisib trial in Japan
12M ago
Pharming Novartis announces first commercial shipments of Joenja in U.S.
PremiumThe FlyPharming Novartis announces first commercial shipments of Joenja in U.S.
1y ago
Pharming initiated with an Outperform at RBC Capital
PremiumThe Fly
Pharming initiated with an Outperform at RBC Capital
1y ago
Pharming price target raised to $40 from $36 at Oppenheimer
PremiumThe Fly
Pharming price target raised to $40 from $36 at Oppenheimer
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100